-
XJTU rises in 2020 QS rankings
March 05, 2020
The 2020 QS World University Rankingwasreleased on March 3rd, 2020, covering 48 disciplines classified into 5 categories.
-
XJTU researchers develop an automatic monitoring and pre-warning system for epidemic control
March 02, 2020
One of the most important methods in epidemic prevention and control is monitoring body temperature, involving daily use of forehead thermometers during outbreaks.
-
A COVID-19 pulmonary infection auxiliary diagnosis system developed
February 24, 2020
According to the Guidelines on the Novel Coronavirus-Infected Pneumonia Diagnosis and Treatment (Tentative, the Fifth Revision), Hubei Province, the epidemic focus in China, added“clinical diagnosis cases”to confirmed cases, meaning that patients show imagery characteristics of pneumonia will be confirmed with COVID-19.
-
XJTU researchers invented China’s first new PCR nucleic acid testing instrument
February 18, 2020
The instrument has been put into production and is already in sure front linehospitals treating COVID-19 throughout China.
-
XJTU develops multifunctional thermometric robots for inspection and disinfection
February 17, 2020
The research team led by XJTU Professor Mei Xuesong has developed a multifunctional robot for measuring body temperature, inspection, and disinfection.
-
Liu Wenyue develops a COVID-19 infection risk big data evaluation model
February 14, 2020
Recently, XJTU's associate professor Liu Wenyue of the School of Management, developed a COVID-19 infection risk big data evaluation model.
-
XJTU’s AI team supports hospitals in 2019-nCov medical screening
February 11, 2020
The Artificial Intelligence in Medicine (AIM) team of XJTU's School of Mathematics and Statistics developed an online health service and medical screening system for the Second Affiliated Hospital of XJTU focused on 2019-nCov prevention and control.
-
XJTU’s progress in finding effective medication for treating 2019-nCov
February 10, 2020
On February 3, 2020, Professor Liu Bing of the First Affiliated Hospital of XJTU, and researchers from Tongji Medical College of Huazhong University of Science &Technology, Wuhan Children's Hospital, CAS Beijing Institute of Genomics, and Huawei Cloud selected 5 antiviral drugs that might be effective in treating 2019-nCov.